Pediatric Gastroenterology, Hepatology & Nutrition

The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition (대한소아소화기영양학회)
권호 표지
DOI QR코드

DOI QR Code

Outcomes of Portosystemic Shunts in Children with and without Liver Transplantation

  • Hamza Hassan Khan (Department of Pediatrics, Shawn Jenkins Children's Hospital, Medical University of South Carolina) ;
  • Stuart S. Kaufman (Department of Pediatrics., Transplant Institute, Medstar Georgetown University Hospital) ;
  • Nada A. Yazigi (Department of Pediatrics., Transplant Institute, Medstar Georgetown University Hospital) ;
  • Khalid M. Khan (Department of Pediatrics., Transplant Institute, Medstar Georgetown University Hospital)
  • Received : 2023.01.08
  • Accepted : 2023.09.12
  • Published : 2024.01.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: Limited data exist regarding outcome and morbidity associated with portosystemic shunts in the pediatric transplant population. Our study assesses the outcomes of pediatric patients who underwent a portosystemic shunt procedure, both with and without liver transplantation (LT). Methods: This study retrospectively reviewed the medical records of pediatric patients aged 0-19 years who underwent shunt placement between 2003 and 2017 at a tertiary care center. The analysis included cases of shunt placement with or without LT. Results: A total of 13 pediatric patients were included in the study with median age of 8.8 years. Among the cases, 11 out of 13 (84.6%) underwent splenorenal shunt, 1 (7.7%) underwent a mesocaval shunt, and another 1 (7.7%) underwent a Modified Rex (mesoportal) shunt. Additionally, 5 out of 13 (38.5%) patients had LT, with 4 out of 5 (80.0%) receiving the transplant before shunt placement, and 1 out of 5 (20.0%) receiving it after shunt placement. Gastrointestinal bleeding resulting from portal hypertension was the indication in all cases. A total of 10 complications were reported in 5 patients; the most common complication was anemia in 3 (23.1%) patients. At the most recent follow-up visit, the shunts were functional without encephalopathy, and no deaths were reported. Conclusion: Shunt placement plays a crucial role in the management of patients with portal hypertension. Our study demonstrates favorable long-term outcomes in pediatric patients who underwent shunt placement. Long term shunt outcomes were similar and unremarkable in patients with LT and without LT.

Keywords

References

  1. Slowik V, Monroe EJ, Friedman SD, Hsu EK, Horslen S. Pressure gradients, laboratory changes, and outcomes with transjugular intrahepatic portosystemic shunts in pediatric portal hypertension. Pediatr Transplant 2019;23:e13387. 
  2. Shneider BL, Bosch J, De Franchis R, Emre SH, Groszmann RJ, Ling SC, et al. Portal hypertension in children: expert pediatric opinion on the report of the Baveno v Consensus Workshop on Methodology of Diagnosis and Therapy in Portal Hypertension. Pediatr Transplant 2012;16:426-37.  https://doi.org/10.1111/j.1399-3046.2012.01652.x
  3. Gauthier F. Recent concepts regarding extra-hepatic portal hypertension. Semin Pediatr Surg 2005;14:216-25.  https://doi.org/10.1053/j.sempedsurg.2005.06.004
  4. Stein EJ, Shivaram GM, Koo KSH, Dick AAS, Healey PJ, Monroe EJ. Endovascular treatment of surgical mesoportal and portosystemic shunt dysfunction in pediatric patients. Pediatr Radiol 2019;49:1344-53.  https://doi.org/10.1007/s00247-019-04458-6
  5. Hsu EK, Murray KF. Cirrhosis and chronic liver failure. In: Suchy FJ, Sokol RJ, Balistreri WF, eds. Liver Disease in Children. 4th ed. Cambridge University Press, 2014:1-46.
  6. Patel N, Grieve A, Hiddema J, Botha J, Loveland J. Surgery for portal hypertension in children: a 12-year review. S Afr Med J 2017;107:12132. 
  7. Weiss B, Shteyer E, Vivante A, Berkowitz D, Reif S, Weizman Z, et al. Etiology and long-term outcome of extrahepatic portal vein obstruction in children. World J Gastroenterol 2010;16:4968-72.  https://doi.org/10.3748/wjg.v16.i39.4968
  8. Chapin CA, Bass LM. Cirrhosis and portal hypertension in the pediatric population. Clin Liver Dis 2018;22:735-52.  https://doi.org/10.1016/j.cld.2018.06.007
  9. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010;362:823-32.  https://doi.org/10.1056/NEJMra0901512
  10. Colli A, Gana JC, Yap J, Adams-Webber T, Rashkovan N, Ling SC, et al. Platelet count, spleen length, and platelet count-to-spleen length ratio for the diagnosis of oesophageal varices in people with chronic liver disease or portal vein thrombosis. Cochrane Database Syst Rev 2017;4:CD008759. 
  11. Witters P, Hughes D, Karthikeyan P, Ramakrishna S, Davenport M, Dhawan A, et al. King's variceal prediction score: a novel noninvasive marker of portal hypertension in pediatric chronic liver disease. J Pediatr Gastroenterol Nutr 2017;64:518-23.  https://doi.org/10.1097/MPG.0000000000001423
  12. Ling SC, Walters T, McKiernan PJ, Schwarz KB, Garcia-Tsao G, Shneider BL. Primary prophylaxis of variceal hemorrhage in children with portal hypertension: a framework for future research. J Pediatr Gastroenterol Nutr 2011;52:254-61.  https://doi.org/10.1097/MPG.0b013e318205993a
  13. D'Antiga L. Medical management of esophageal varices and portal hypertension in children. Semin Pediatr Surg 2012;21:211-8.  https://doi.org/10.1053/j.sempedsurg.2012.05.004
  14. Blachman-Braun R, Lopez-Verdugo F, Alonso D, Book L, Feola GP, Rodriguez-Davalos MI. Revision of meso-Rex bypass utilizing a collateral vein in a patient with portal steal phenomenon after liver transplant: a case report. Int J Surg Case Rep 2019;60:230-3.  https://doi.org/10.1016/j.ijscr.2019.05.051
  15. De Ville de Goyet J, D'Ambrosio G, Grimaldi C. Surgical management of portal hypertension in children. Semin Pediatr Surg 2012;21:219-32.  https://doi.org/10.1053/j.sempedsurg.2012.05.005
  16. Emre S, Dugan C, Frankenberg T, Hudgins LC, Gagliardi R, Artis AT, et al. Surgical portosystemic shunts and the Rex bypass in children: a single-centre experience. HPB (Oxford) 2009;11:252-7.  https://doi.org/10.1111/j.1477-2574.2009.00047.x
  17. Lillegard JB, Hanna AM, McKenzie TJ, Moir CR, Ishitani MB, Nagorney DM. A single-institution review of portosystemic shunts in children: an ongoing discussion. HPB Surg 2010;2010:964597.
  18. Scholz S, Sharif K. Surgery for portal hypertension in children. Curr Gastroenterol Rep 2011;13:279-85.  https://doi.org/10.1007/s11894-011-0186-8
  19. Mishra PK, Patil NS, Saluja S, Narang P, Solanki N, Varshney V. High patency of proximal splenorenal shunt: a myth or reality? - a prospective cohort study. Int J Surg 2016;27:82-7.  https://doi.org/10.1016/j.ijsu.2015.12.071
  20. Dasgupta R, Roberts E, Superina RA, Kim PC. Effectiveness of Rex shunt in the treatment of portal hypertension. J Pediatr Surg 2006;41:108-12.  https://doi.org/10.1016/j.jpedsurg.2005.10.059
  21. Ketelsen D, Warmann SW, Schaefer JF, Haber P, Fuchs J, Claussen CD, et al. Percutaneous revascularization of reoccluded meso-rex shunts in extrahepatic portal vein obstruction. J Pediatr Surg 2012;47:E23-8.  https://doi.org/10.1016/j.jpedsurg.2012.04.011
  22. Prasad AS, Gupta S, Kohli V, Pande GK, Sahni P, Nundy S. Proximal splenorenal shunts for extrahepatic portal venous obstruction in children. Ann Surg 1994;219:193-6. https://doi.org/10.1097/00000658-199402000-00011